| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |